PapersFlow Research Brief
Ophthalmology and Visual Impairment Studies
Research Guide
What is Ophthalmology and Visual Impairment Studies?
Ophthalmology and Visual Impairment Studies is a field within medicine and epidemiology that examines the global prevalence, risk factors, progression, and interventions for conditions such as myopia, refractive errors, visual impairment, and related ocular disorders.
This field encompasses 66,127 published works on the epidemiology of myopia and visual impairment. Studies address prevalence, temporal trends, environmental and genetic risk factors, and treatments including orthokeratology and atropine therapy. Key focus areas include childhood myopia, uncorrected refractive errors, and complications leading to vision loss.
Topic Hierarchy
Research Sub-Topics
Global Epidemiology of Myopia
Synthesizes prevalence data, temporal trends, and projections for myopia worldwide. Researchers model risk factors like near-work and urbanization.
Childhood Myopia Progression
Examines longitudinal progression rates, genetic predispositions, and environmental triggers in children. Studies evaluate biometric changes via axial length.
Atropine Therapy for Myopia Control
Evaluates low-dose atropine efficacy, side effects, and rebound phenomena in randomized trials. Research optimizes dosing for axial elongation inhibition.
Orthokeratology for Refractive Error
Investigates overnight rigid lens wear for corneal reshaping and myopia slowing. Studies measure efficacy, safety, and adherence.
Uncorrected Refractive Errors Impact
Quantifies disability-adjusted life years lost to uncorrected errors globally. Research assesses economic and quality-of-life burdens.
Why It Matters
Ophthalmology and Visual Impairment Studies informs public health planning by projecting that high myopia will affect nearly 1 billion people by 2050, necessitating services to manage ocular complications and prevent vision loss, as shown in 'Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050' (Holden et al., 2016). In 2002, visual impairment affected an estimated 161 million people worldwide, with uncorrected refractive errors as a leading cause, highlighting opportunities for avoidable blindness reduction (Resnikoff et al., 2004). Among U.S. adults over 40, visual impairment impacts 1 in 28 individuals, with causes varying by race and ethnicity, and prevalence expected to rise due to population aging (Congdon et al., 2004). These data support interventions like VISION 2020 targets to address avoidable blindness (Steinmetz et al., 2020).
Reading Guide
Where to Start
'Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050' by Holden et al. (2016), as it provides foundational global estimates and projections essential for understanding myopia epidemiology.
Key Papers Explained
Holden et al. (2016) 'Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050' establishes rising myopia trends, building on Resnikoff et al. (2004) 'Global data on visual impairment in the year 2002,' which quantifies baseline visual impairment causes. Congdon et al. (2004) 'Causes and Prevalence of Visual Impairment Among Adults in the United States' extends this to U.S. demographics, while Steinmetz et al. (2020) 'Causes of blindness and vision impairment in 2020 and trends over 30 years' analyzes 30-year global trends against VISION 2020. Bourne et al. (2017) 'Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment' further projects blindness metrics, connecting prevalence data across decades.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent analyses like Steinmetz et al. (2020) emphasize ongoing trends in avoidable blindness related to VISION 2020. Bourne et al. (2017) projects future burdens of distance and near vision impairment. No preprints or news from the last 12 months available.
Papers at a Glance
Frequently Asked Questions
What is the projected global prevalence of high myopia by 2050?
Holden et al. (2016) in 'Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050' project significant increases in myopia and high myopia prevalences globally from 2000 to 2050. High myopia is expected to affect almost 1 billion people, raising risks of ocular complications and vision loss. These estimates guide planning for myopia management services.
What were the main causes of visual impairment worldwide in 2002?
Resnikoff et al. (2004) in 'Global data on visual impairment in the year 2002' estimated 161 million people with visual impairment, including 37 million blind. Uncorrected refractive errors were a primary cause, alongside cataract and glaucoma. Data derived from recent studies using International Classification of Diseases definitions.
How is age-related cataract graded in studies?
Chylack (1993) developed the Lens Opacities Classification System III (LOCS III) for grading slit-lamp and retroillumination images of age-related cataract. LOCS III improves upon prior systems for consistent clinical assessment. It standardizes evaluation across research and practice.
What is the prevalence of visual impairment among U.S. adults?
Congdon et al. (2004) in 'Causes and Prevalence of Visual Impairment Among Adults in the United States' report blindness or low vision affects 1 in 28 Americans over 40. Causes vary by race/ethnicity, with prevalence set to increase markedly over the next 20 years due to aging. This underscores needs for targeted interventions.
What tools assess visual function in clinical trials?
Mangione et al. (2001) developed the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25). It matches the reliability and validity of the 51-item version while being shorter for trials. Preliminary analyses confirm its utility in diverse settings.
How is eye movement training used for visual field loss?
Sahraie et al. (2016) in 'Use of NeuroEyeCoach™ to Improve Eye Movement Efficacy in Patients with Homonymous Visual Field Loss' describe compensatory therapy via systematic training. It addresses inefficient visual search in patients with retinogeniculostriate damage. NeuroEyeCoach™ enables effective coping strategies.
Open Research Questions
- ? What are the precise environmental and genetic interactions driving childhood myopia progression?
- ? How effective are orthokeratology and atropine in long-term myopia control across global populations?
- ? What temporal trends in avoidable blindness persist despite VISION 2020 interventions?
- ? How do racial and ethnic differences influence causes and prevalence of blindness in aging populations?
- ? What metrics best quantify visual function improvements from compensatory therapies in field loss patients?
Recent Trends
Global prevalence projections for myopia and high myopia show increases from 2000-2050 per Holden et al.
2016Steinmetz et al. report trends over 30 years for blindness causes in relation to VISION 2020.
2020Bourne et al. provide systematic reviews of blindness and vision impairment projections.
2017No recent preprints or news coverage available.
Research Ophthalmology and Visual Impairment Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ophthalmology and Visual Impairment Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers